BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 2646895)

  • 21. A multicenter comparison of lovastatin and probucol for treatment of severe primary hypercholesterolemia. The Lovastatin Study Group IV.
    Am J Cardiol; 1990 Sep; 66(8):22B-30B. PubMed ID: 2206033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Swiss simvastatin multicenter study: 1. Efficacy of 10 mg simvastatin daily in patients with primary hypercholesterolemia].
    Riesen WF; Keller U; Del Bufalo A; Reutter FW; Baur HR; Golay A; Bertel O; Kummer H; Kistler H; Ammann F
    Schweiz Med Wochenschr; 1989 Dec; 119(48):1719-23. PubMed ID: 2694363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative effects of simvastatin and lovastatin in patients with hypercholesterolemia. The Simvastatin and Lovastatin Multicenter Study Participants.
    Farmer JA; Washington LC; Jones PH; Shapiro DR; Gotto AM; Mantell G
    Clin Ther; 1992; 14(5):708-17. PubMed ID: 1468089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of primary hypercholesterolaemia. Short-term efficacy and safety of increasing doses of simvastatin and pravastatin: a double-blind comparative study.
    Stalenhoef AF; Lansberg PJ; Kroon AA; Kortmann B; De Haan AF; Stuyt PM; Kastelein JJ
    J Intern Med; 1993 Jul; 234(1):77-82. PubMed ID: 8326293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of simvastatin and probucol in hypercholesterolemia (Simvastatin Multicenter Study Group II).
    Pietro DA; Alexander S; Mantell G; Staggers JE; Cook TJ
    Am J Cardiol; 1989 Mar; 63(11):682-6. PubMed ID: 2646895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simvastatin. A reappraisal of its pharmacology and therapeutic efficacy in hypercholesterolaemia.
    Plosker GL; McTavish D
    Drugs; 1995 Aug; 50(2):334-63. PubMed ID: 8521762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simvastatin. A review of its pharmacological properties and therapeutic potential in hypercholesterolaemia.
    Todd PA; Goa KL
    Drugs; 1990 Oct; 40(4):583-607. PubMed ID: 2083515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia.
    Hsu I; Spinler SA; Johnson NE
    Ann Pharmacother; 1995; 29(7-8):743-59. PubMed ID: 8520093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
    Lennernäs H; Fager G
    Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of familial and non-familial hypercholesterolaemia: a review of HMG-CoA reductase inhibitors and probucol.
    Tikkanen MJ; Helve E; Nikkilä EA
    Eur Heart J; 1987 Aug; 8 Suppl E():97-101. PubMed ID: 3315684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and tolerability of simvastatin (MK-733).
    Stalenhoef AF; Mol MJ; Stuyt PM
    Am J Med; 1989 Oct; 87(4A):39S-43S. PubMed ID: 2679083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simvastatin: a review of its pharmacology and clinical use.
    Mauro VF; MacDonald JL
    DICP; 1991 Mar; 25(3):257-64. PubMed ID: 2028634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lovastatin and simvastatin prevention studies.
    Jones PH
    Am J Cardiol; 1990 Sep; 66(8):39B-43B. PubMed ID: 2206035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Currently available hypolipidaemic drugs and future therapeutic developments.
    Farmer JA; Gotto AM
    Baillieres Clin Endocrinol Metab; 1995 Oct; 9(4):825-47. PubMed ID: 8593127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipid lowering drugs in atherosclerosis--the HMG-CoA reductase inhibitors.
    Mantell G
    Clin Exp Hypertens A; 1989; 11(5-6):927-41. PubMed ID: 2676263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Probucol in long-term treatment of hypercholesterolemia.
    Strandberg TE; Vanhanen H; Miettinen TA
    Gen Pharmacol; 1988; 19(3):317-20. PubMed ID: 3046993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and long-term adverse effect pattern of lovastatin.
    Tobert JA
    Am J Cardiol; 1988 Nov; 62(15):28J-34J. PubMed ID: 3055921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of hyperlipidemia of kidney disease.
    Grundy SM
    Kidney Int; 1990 Mar; 37(3):847-53. PubMed ID: 2179614
    [No Abstract]   [Full Text] [Related]  

  • 39. Probucol: pharmacology and clinical application.
    Zimetbaum P; Eder H; Frishman W
    J Clin Pharmacol; 1990 Jan; 30(1):3-9. PubMed ID: 2406299
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.